Total Payments
$5,389
2024 Payments
$1,330
Companies
17
Transactions
289
Medicare Patients
18,027
Medicare Billing
$3.0M
Payment Breakdown by Category
Food & Beverage$5,389 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,389 | 289 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,296 | 165 | $0 (2024) |
| Medtronic, Inc. | $588.41 | 30 | $0 (2024) |
| PFIZER INC. | $377.69 | 46 | $0 (2018) |
| Boston Scientific Corporation | $365.47 | 18 | $0 (2024) |
| PAINTEQ LLC | $219.89 | 6 | $0 (2024) |
| Relievant Medsystems, Inc. | $99.79 | 2 | $0 (2023) |
| SI-BONE, Inc. | $89.80 | 4 | $0 (2022) |
| Nevro Corp. | $86.12 | 3 | $0 (2018) |
| Medtronic USA, Inc. | $79.36 | 5 | $0 (2020) |
| Pacira Pharmaceuticals Incorporated | $52.43 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,330 | 57 | Medtronic, Inc. ($588.41) |
| 2023 | $926.77 | 36 | Abbott Laboratories ($783.89) |
| 2022 | $548.61 | 22 | Abbott Laboratories ($409.39) |
| 2021 | $664.06 | 29 | Abbott Laboratories ($603.36) |
| 2020 | $380.02 | 28 | Abbott Laboratories ($367.52) |
| 2019 | $468.65 | 27 | Abbott Laboratories ($230.72) |
| 2018 | $595.13 | 42 | Abbott Laboratories ($296.11) |
| 2017 | $475.69 | 48 | PFIZER INC. ($221.39) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Neuromodulation | ||||||
| 12/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Medtronic, Inc. | PRIMEADVANCED SURESCAN (Device) | Food and Beverage | In-kind items and services | $47.21 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/16/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Neuromodulation | ||||||
| 12/16/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: Neuromodulation | ||||||
| 12/07/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Drug Infusion Systems | ||||||
| 11/14/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Drug Infusion Systems | ||||||
| 11/14/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Drug Infusion Systems | ||||||
| 11/11/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/24/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Neuromodulation | ||||||
| 10/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: Neuromodulation | ||||||
| 10/21/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $48.70 | General |
| Category: Drug Infusion Systems | ||||||
| 10/10/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/03/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $39.85 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/18/2024 | Medtronic, Inc. | KYPHON EXPRESS II KYPHOPAK TRAY (Device) | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/29/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Drug Infusion Systems | ||||||
| 08/15/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/13/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $36.64 | General |
| Category: Drug Infusion Systems | ||||||
| 08/09/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 4,535 | 13,074 | $3.1M | $727,472 |
| 2022 | 36 | 4,421 | 16,492 | $3.3M | $786,819 |
| 2021 | 41 | 4,686 | 18,655 | $3.6M | $842,806 |
| 2020 | 44 | 4,385 | 15,210 | $3.0M | $605,201 |
Total Patients
18,027
Total Services
63,431
Medicare Billing
$3.0M
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 449 | 1,740 | $741,240 | $158,265 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 525 | 1,970 | $571,300 | $130,685 | 22.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 191 | 259 | $229,215 | $61,590 | 26.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 101 | 124 | $200,632 | $60,061 | 29.9% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 102 | 125 | $83,125 | $33,631 | 40.5% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 192 | 364 | $142,324 | $31,907 | 22.4% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 12 | 24 | $150,432 | $31,450 | 20.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 96 | 155 | $104,625 | $28,155 | 26.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 170 | 170 | $137,700 | $25,845 | 18.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 211 | 427 | $100,772 | $18,016 | 17.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 93 | 119 | $74,732 | $16,961 | 22.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 96 | 153 | $52,632 | $14,965 | 28.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 217 | 377 | $74,269 | $14,334 | 19.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 26 | 31 | $50,716 | $13,085 | 25.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 40 | 57 | $42,294 | $11,319 | 26.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 216 | 304 | $65,968 | $10,915 | 16.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 40 | 53 | $52,311 | $10,130 | 19.4% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 25 | 30 | $21,960 | $7,654 | 34.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 95 | 155 | $38,750 | $6,769 | 17.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 63 | 78 | $30,030 | $6,667 | 22.2% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 28 | 113 | $38,646 | $6,582 | 17.0% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 40 | 57 | $21,147 | $6,027 | 28.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 282 | 490 | $24,990 | $6,003 | 24.0% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 39 | 73 | $22,046 | $4,416 | 20.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 12 | 20 | $19,500 | $3,965 | 20.3% |
About Dr. Jerod Shaw, MD
Dr. Jerod Shaw, MD is a Physical Medicine & Rehabilitation healthcare provider based in Marble Falls, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407030836.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerod Shaw, MD has received a total of $5,389 in payments from pharmaceutical and medical device companies, with $1,330 received in 2024. These payments were reported across 289 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($5,389).
As a Medicare-enrolled provider, Shaw has provided services to 18,027 Medicare beneficiaries, totaling 63,431 services with total Medicare billing of $3.0M. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Pain Medicine
- Location Marble Falls, TX
- Active Since 12/20/2007
- Last Updated 06/28/2017
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1407030836
Products in Payments
- PROCLAIM (Device) $1,247
- Octrode SCS Leads (Device) $731.35
- Proclaim Family of SCS IPGs (Device) $403.20
- LYRICA (Drug) $358.37
- INTELLIS ADAPTIVESTIM (Device) $322.37
- ETERNA (Device) $311.32
- Proclaim IPG (Device) $304.58
- PAINTEQ (Device) $219.89
- SYNCHROMEDII (Device) $150.51
- SCS IPGs (Device) $107.37
- Intracept (Device) $99.79
- INFINION (Device) $94.86
- OCTRODE (Device) $88.07
- Senza Spinal Cord Stimulation System (Device) $86.12
- SCS leads (Device) $85.94
- SPECTRA WAVEWRITER (Device) $69.86
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $68.32
- General - Pain Management (Device) $56.13
- PRIMEADVANCED SURESCAN (Device) $47.21
- INTELLIS (Device) $38.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.